Skip to content

Leuprolide: Uses, Side Effects, and How It Is Given

Published: July 26, 2026Updated: July 26, 2026

Leuprolide is a hormone medicine that reduces the production of sex hormones. Depending on the formulation, it is used to treat prostate cancer, endometriosis, uterine fibroids, precocious puberty, or to support fertility treatment.

Quick summary

Leuprolide is given by injection or as a slow-release implant on a product-specific schedule. Use it exactly as prescribed and ask your doctor or pharmacist about side effects, interactions, and the correct formulation for you.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
L02AE02
RxNorm
42375
Generic
Leuprolide
Class
atc-l02
Brands
Lupron, Fensolvi, Camcevi, Lutrate, Vabrinty, Eligard
Availability
rx
Lactation
unknown
Routes
—
Forms
prefilled syringe, suspension, injection, solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose significantly exceeding recommended monthly or quarterly amounts that may cause serious toxicity
Chronic overdose: Prolonged use leading to sustained suppression of gonadotropins and sex hormones
Immediate actions
Monitor vital signs, provide supportive care, observe for allergic reactions
Antidote
No specific antidote exists(Treatment is supportive and symptomatic)
Poison Control: 1-800-222-1222

Special Populations

6 groups
✗

pregnancy

all trimesters
contraindicated
FDA Category
X
Dose Adjustment

avoid use

Key Recommendations

contraindicated in pregnancy due to potential for fetal harm and loss of pregnancy

Monitor

discontinue immediately if pregnancy occurs

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
X
Dose Adjustment

discontinue breastfeeding

Key Recommendations

not recommended during breastfeeding; drug suppresses lactation and may be excreted in breast milk

Monitor

monitor infant for any adverse effects

Use of this medication in this population requires careful consideration of risks and benefits.

✓

geriatric

elderly
safe
FDA Category
N
Dose Adjustment

no specific adjustment

Key Recommendations

use standard dosing; monitor for cardiovascular and metabolic effects commonly seen in elderly

Monitor

regular cardiovascular monitoring, bone density assessment, blood glucose monitoring

⚠

pediatric_age

prepubertal children
caution
FDA Category
X
Dose Adjustment

weight-based dosing

Key Recommendations

indicated for central precocious puberty; use under specialist supervision only

Monitor

monitor growth velocity, bone age, pubertal progression, and endocrine function

Use with caution and monitor for adverse effects.

✓

renal_impairment

mild to moderate
safe
FDA Category
N
Dose Adjustment

no dose adjustment required

Key Recommendations

no dose adjustment needed for mild to moderate renal impairment; use standard dosing

Monitor

standard monitoring appropriate

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

use with caution

Key Recommendations

limited clinical data; use with caution in hepatic impairment

Monitor

monitor liver function tests periodically

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1985

Original FDA approval year for Leuprolide acetate

drug_classWHO
2023

Drug class

Value:GnRH agonist

GnRH (gonadotropin-releasing hormone) agonist classification

usageMedical guidelines
2023

Common uses

Value:Prostate cancer, endometriosis, central precocious puberty, uterine fibroids

Primary therapeutic indications for Leuprolide

mechanismFDA
2023

Mechanism of action

Value:GnRH receptor agonist that suppresses gonadotropin release and reduces testosterone/estrogen production

Pharmacological mechanism of action

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy